Tuberculosis treatment in a refugee and migrant population: 20 years of experience on the Thai-Burmese border

outcome, 13.5% defaulted, 7.6% died and 1.3% failed treatment. Multivariate analysis for new cases showed higher likelihood of adverse outcomes for patients who were Burmese migrants or Thai villagers, male, aged >15 years or with smear-negative pulmonary TB. CONCLUSION: These fi ndings suggest that treatment outcomes depend on the programme’s capacity to respond to specifi c patients’ constraints. High-risk groups, such as migrant populations, need a patient-centred approach, and specifi c, innovative strategies have to be developed based on the needs of the most vulnerable and marginalised populations.